The Binding Site GmbH

The Binding Site GmbH is a company in Schwetzingen, Germany that has taken part in 2 EU-funded projects since 2008, receiving €103k in EU funding.

EU funding received€103k
EU projects2
As coordinator0
Running now0
First EU project2008
Latest project2012
CountryGermany
EU registration (PIC)998771656
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are The Binding Site GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€103k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • OPTATIOPartner

    OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €37ktheir share
  • EURO-PADNETPartner

    The Pathophysiology and Natural Course of Patients with Primary Antibody Deficiencies (PAD)

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €66ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • drug discovery
  • drug resistance
  • immunology
  • mortality
  • mutation
  • pathophysiology
  • personalized medicine

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime